miscsubjectsAI governance
Evidence review

Tesamorelin for Cognition: Human Trial Data and Evidence Layers

· · 3 min read
bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `tesamorelin-cognition`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/tesamorelin-cognition

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/tesamorelin-cognition/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/tesamorelin-cognition/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/tesamorelin-cognition/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/tesamorelin-cognition/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

Why Tesamorelin might help you

  1. Therefore for you: If that layer is part of your problem, Tesamorelin is discussed because it targets repair (tissue) — not because it masks pain.

How these fit together

Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.

  • Tesamorelin → GH axis / visceral fat

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 2
  • Claims tagged human evidence: 2
  • Claims tagged preclinical (animal/lab): 1
  • Claims tagged anecdotal: 2
  • Reddit posts catalogued: 1
  • X posts catalogued: 1
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 4

Quantified confidence (this ledger): 0.36 / 1.00 — low–moderate — mostly preclinical

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Effects of growth hormone–releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults: a randomized controlled trial (source s1)

Baker 2012 RCT details and results.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Effects of Tesamorelin on Neurocognitive Impairment in Persons With HIV and Abdominal Obesity (source s2)

Ellis 2025 trial results.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

What people say on Reddit

Full text Effects of Growth Hormone–Releasing Hormone [tesamorelin] on Cognitive Function — Reddit, r/Nootropics (source s3)

Reddit thread referencing trial.

What people say on X

X post on tesamorelin visceral fat and cognition — X (source s4)

X mechanistic discussion.

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

Explore this article's relationships

Cognition / focus · condition map

Connected articles

Where this sits in the evidence graph. Open the full interactive map for the whole neighborhood.

Full map →
RelatedTesamorelin · 5 humanTesamorelin for Statin-Associated Cognitive Effects: Human Trial Evide… · 5 humanTesamorelin for Carpal Tunnel Syndrome: Evidence Review · 4 humanTesamorelin for Chemotherapy: Body Composition Evidence and Symptom Su… · 4 human
Evidence · 4 sources · swipe →chain 6c7d80c0d752 · verify chain · provenance
1 / 4
Evidence ledger 5 · tier-ranked · API
human
One 20-week RCT in 152 older adults found tesamorelin improved executive function (P=.005) and showed a trend for verbal memory (P=.08).
sources: s1
human
A 2025 open-label trial in 73 HIV patients with abdominal obesity found no significant between-group cognitive difference versus standard of care despite waist reduction.
sources: s2
preclinical
No preclinical (rat or other animal) studies on tesamorelin and cognition were identified in searched literature.
anecdotal
X posts discuss mechanistic links via visceral fat and insulin sensitivity but contain no individual outcome reports.
sources: s4
anecdotallow confidence
Reddit discussions reference the 2012 trial but report no personal cognition outcome data for tesamorelin.
sources: s3
Model review1 contributions · 1 modelExpand the recursive review layer
1 / 1
grok/grok-4.3writer
redraft2026-06-29 23:24
Tesamorelin for Cognition: Human Trial Data and Evidence Layers · 5 claims · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: Tesamorelin for Cognition
Slug: tesamorelin-cognition
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"single_focus","condition":null,"condition_key":null,"primary_peptide":null,"peptides_in_scope":[{"id":"tesamorelin","name":"Tesamorelin"}],"drugs_in_scope":[],"weight_sensitive":false,"stimulant_context":false,"breaking_down":{"section_title":"What's breaking down","degenerative_why
it output
{"slug":"tesamorelin-cognition","title":"Tesamorelin for Cognition: Human Trial Data and Evidence Layers","body":"## What's breaking down\n\nCognitive function can decline with age through reduced growth hormone (GH) and insulin-like growth factor 1 (IGF-1) signaling. Visceral fat accumulation adds inflammatory load that may impair brain insulin sensitivity and hippocampal performance. These layers compound: lower GH axis activity limits tissue repair signals while excess abdominal fat sustains low-grade inflammation that affects executive function and memory. Tesamorelin is discussed here because it stimulates endogenous GH release, a pathway tied to both visceral fat reduction and potential brain repair signals, rather than symptom masking.\n\n## Why Tesamorelin might help you\n\nIf declining GH/IGF-1 signaling and visceral fat contribute to your cognitive profile, Tesamorelin targets the GH axis directly.\n\n1. Tesamorelin binds GHRH receptors in the pituitary.\n2. This raises pulsatile GH output and circulating IGF-1 within physiological ranges.\n3. Elevated IGF-1 supports neuronal maintenance and may improve executive function measures.\n4. Parallel visceral fat reduction lowers inflammatory signals that can blunt brain insulin response.\n\nTherefore for you: If that layer is part of your problem, Tesamorelin is discussed because it targets repair (tissue) — not because it
4b361c5b877bda02
Machine verification: /api/articles/tesamorelin-cognition/contributions

Related articles

Cognition / focus · condition map

Open evidence map →
TesamorelintesamorelinTesamorelin for Benzodiazepine Withdrawal: Evidence Reviewtesamorelin-benzo-withdrawalTesamorelin for Benzodiazepines: Evidence Reviewtesamorelin-benzodiazepinesTesamorelin for Statin-Associated Cognitive Effects: Human Trial Evide…tesamorelin-brain-fogTesamorelin for Carpal Tunnel Syndrome: Evidence Reviewtesamorelin-carpal-tunnelTesamorelin for Chemotherapy: Body Composition Evidence and Symptom Su…tesamorelin-chemo
Ask this article · 8 suggested prompts
topology · JSON · question graph

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (human tier): "One 20-week RCT in 152 older adults found tesamorelin improved executive function (P=.005) and showed a trend for verbal memory (P=.08)."?
ask tesamorelin-cognition claim c1 · paste includes §SELF
What does the ledger say about this (human tier): "A 2025 open-label trial in 73 HIV patients with abdominal obesity found no significant between-group cognitive difference versus standard of…"?
ask tesamorelin-cognition claim c2 · paste includes §SELF
What does the ledger say about this (preclinical tier): "No preclinical (rat or other animal) studies on tesamorelin and cognition were identified in searched literature."?
ask tesamorelin-cognition claim c3 · paste includes §SELF
What does the ledger say about this (anecdotal tier): "X posts discuss mechanistic links via visceral fat and insulin sensitivity but contain no individual outcome reports."?
ask tesamorelin-cognition claim c5 · paste includes §SELF
What does the ledger say about this (anecdotal tier): "Reddit discussions reference the 2012 trial but report no personal cognition outcome data for tesamorelin."?
ask tesamorelin-cognition claim c4 · paste includes §SELF
Summarize this reddit report and how it should weigh: "Reddit thread referencing trial"
ask tesamorelin-cognition source s3 · paste includes §SELF
Summarize this x report and how it should weigh: "X mechanistic discussion"
ask tesamorelin-cognition source s4 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about Tesamorelin for Cognition: Human Trial Data and Evidence Layers — and what would you need me to tell you first?
ask tesamorelin-cognition condition gaps · paste includes §SELF
Add your experience or question
Think this article is wrong?
Call bullshit on CharlieOS →
Loading more articles…